Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

Event Summaries about HIV/AIDS

  • June 28–29, 2023
    Researchers, pharmacists and pharmacy professionals, community members, and federal partners discussed how pharmacies are used to provide HIV testing, prevention, and care.
  • November 9, 2022
    In a virtual fireside chat, Serena Spudich, M.D., M.A., and NIMH Director Joshua A. Gordon, M.D., Ph.D., will discuss the impact of HIV-1 and SARS-CoV-2 viruses on the central nervous system, similarities and differences in the pathology and clinical effects, and how this knowledge could inform research and interventions for SARS-CoV-2.
  • August 11, 2022
    As children prepare to return to school during these uncertain times, NIMH is conducting a Facebook Live event on the nation’s youth mental health crisis featuring Deputy Director Shelli Avenevoli, Ph.D.
  • October 13–14, 2021
    NIMH and the Ragon Institute of MGH, MIT, and Harvard conducted a virtual meeting on the emerging data related to macrophage interactions with the immune system during HIV infection, macrophage reservoirs and approaches to their elimination, and the involvement of CNS myeloid reservoirs and associated co-morbidities. The meeting also highlighted recent work on macrophage inflammation in the context of SARS-CoV-2 infection and work from new NIMH-funded investigators.
  • July 14–15, 2021
    This meeting examined emerging data related to neurologic and psychiatric complications of SARS-CoV-2 infection and possible interactions with other infections such as HIV.
  • May 24–25, 2021
    Prominent researchers share their perspectives on human mobility and its impact on HIV transmission, prevention, and care.
  • July 13–18, 2020
    On July 13, the National Institute of Mental Health held a virtual meeting to help promote HIV prevention and treatment science, as well as inform the Ending the HIV Epidemic initiative (EHE) and HIV efforts worldwide through furthering HIV-related intersectional stigma and discrimination research advances and opportunities.
  • November 10, 2018
    San Diego, CA; Pre-Conference Learning Institute at American Public Health Association Annual Meeting
    The NIMH Division of AIDS Research hosted a meeting to address diversity mentoring programs to strengthen the HIV research workforce of Latina/Hispanic female investigators with added focus to address contextual factors affecting women living with HIV.
  • October 29, 2018
    Rockville, MD
    The NIMH Division of AIDS Research hosted a workshop to discuss the novel imaging technologies that can be used to detect persistent HIV in the central nervous system (CNS) as well as understand the pathways and mechanisms leading to CNS dysfunction in the antiretroviral therapy era.
  • September 12, 2018
    Rockville, MD
    This workshop covered the neuropsychiatric side effects of Antiretroviral Therapy (ART), and the potential for ART-mediated neurological toxicity when used across the lifespan of HIV.
  • October 23–24, 2017
    Bethesda, MD
    Despite the effectiveness of Anti-retroviral therapy (ART), HIV-induced CNS dysfunction persists, but a significant heterogeneity in the prevalence and severity of these disturbances still exist. Brain autopsy findings from HIV positive individuals on ART have revealed a paucity of the distinctive pathologic findings seen in the pre-ART era.
  • October 11–14, 2017
    Pollenzo, Italy
    The NIMH Division of AIDS Research sponsored a session on “Approach to Consortium Studies of CNS HIV Escape” that was held in conjunction with the Seventh International Meeting on HIV infection in the CNS.
  • September 13–15, 2017
    Krakow, Poland
    The NIMH Division of AIDS Research hosted a session entitled “Blood– brain barrier and HIV reservoirs in the CNS—formation and eradication” in conjunction with the 20th International Symposium on Signal Transduction at the Blood–Brain Barriers.
  • May 10, 2017
    Bethesda, MD
    The NIMH Division of AIDS Research sponsored a meeting to advance the science of HIV pre-exposure prophylaxis (PrEP) implementation.
  • March 13–14, 2017
    Rockville, MD
    The NIMH Division of AIDS Research co-sponsored a meeting with the National Institute of Allergy and Infectious Diseases (NIAID) to advance the next-generation of HIV medication adherence.
  • November 7, 2016
    Rockville, MD
    The NIMH Division of AIDS Research sponsored a workshop to identify significant and unique courses of study aimed at elucidating the complex behavioral and biological relationships between stress and HIV.
  • June 9, 2016
    Bethesda, MD
    The NIMH Division of AIDS Research, with support from the NIH Office of AIDS Research, sponsored a meeting to establish a Global HIV-1 CSF Escape Consortium. Despite stable and successful control of HIV with Antiretroviral Therapy (ART) in the periphery, some patients still have detectable HIV virus in the cerebrospinal fluid (CSF), termed “CSF escape.” Meeting participants discussed prevalence rates, causes, and key scientific research priorities pertaining to HIV-1 CSF escape.